Sep 08, 2026
1:25
For every 25 shares held, investors received 1. The price per share adjusted from $0.21 to $0.01.
The split itself did not change the total investment value.
GT Biopharma, Inc. (GTBP) trades on the NASDAQ Capital Market in the Biotechnology industry.
GT Biopharma, Inc. company overviewThe latest split shown was on September 8, 2026. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
This history records 6 reverse splits between October 21, 1998 and September 8, 2026.